19 May 2013
Keywords: antisoma, reports, narrowed, losses, future, strong, roche
Article | 29 September 2003
The UK's Antisoma, which specializes in the development of monoclonal antibodies, has reported a sharp improvement in losses for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2003
17 May 2013
© 2013 thepharmaletter.com